针对兴奋剂的替代疗法 betel quid 依赖: 一个概念验证研究研究的证明
Peter G Osborne1, Ragavendra Rao Pasupuleti2, Chien-Hung Lee3,4,5
1Baongong Agriscience Center, Fengtian, Taiwan.
Addiction biology
|February 21, 2024
概括
刺激性贝特尔 (SBQ) 的会引起生理刺激,与非刺激性版本不同. 一种新型的SBQ与Mg(OH) 2提供了一个潜在的更安全的替代品,而不是传统的淡化石灰配方.
科学领域:
- 药理学 药理学是指药理学的学科.
- 口腔健康 口腔健康
- 成研究 研究成研究
背景情况:
- 刺激性贝特尔 (SBQ) 是一种令人上,致癌的物质,被数以百万计的人.
- 目前的SBQ配方缺乏有效的药物治疗依赖.
- 传统的SBQ使用淡化,这可能会产生有害影响.
研究的目的:
- 为了比较在体内的生理效应,不同的贝特尔配方.
- 为了将生理反应与体外类化合物水平相关联.
- 为了研究一种新的SBQ配方,使用Mg(OH) 2作为化剂.
主要方法:
- 非兴奋剂贝特尔叶+阿雷卡坚果 (LAN),传统的SBQ (石灰) 和新型的SBQ (Mg(OH) 的比较2).
- 在体内测量中毒的生理参数.
- 在体外分析化物水平使用UHPLC-MS/MS.
主要成果:
- LAN没有刺激作用,尽管含有高的阿雷科林.
- 传统的SBQ和新型的SBQ都诱导了相当的刺激生理反应.
- 石灰水解了肌酸,而Mg (OH) 2则没有.
结论:
- 来自SBQ的生理刺激与植物化学脂质溶解度的pH诱导变化有关.
- 一种新型的SBQ含有Mg(OH) 2可以诱导与传统的SBQ类似的生理效应.
- 更安全的SBQ替代品和改进的戒烟计划是潜在的进步.
关键词:
阿雷卡教科书的教堂(Mg) 2 (OH) 2 (Mg) 2 (OH) 2 (Mg) 2 (Mg) 2 (OH) 2 (Mg) 2 (Mg) 2 (Mg) 2 (Mg) 2 (Mg) 2 (Mg) 3 (Mg) 2 (Mg) 2 (Mg) 2 (Mg) 3 (Mg) 2 (Mg) 2 (Mg) 2 (Mg) 3 (Mg) 2 (Mg) 2 (Mg) 3 (Mg) 2 (Mg) 2 (Mg) 3 (Mg) 3 (Mg) 3 (Mg) 4 (Mg) 3 (Mg) 3 (Mg) 4 (Mg) (Mg) (Mg) 3 ()口腔癌是一种口腔癌.在UHPLC-MS/MS中使用.吸毒成 吸毒成是一种成.这种依赖的依赖性.相关概念视频
Drug Dependence
1.0K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.0K
Drugs Acting on Autonomic Ganglia: Stimulants
1.3K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.3K
Stimulants
195
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
195
Drug Therapy
44
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
44
CNS Depressants: Alcohol and Nicotine
209
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
209
Electroconvulsive Therapy
39
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
39


